[1] Ross D S , Burch H B , Cooper D S , et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis[J]. Thyroid, 2016: 2016, 26(10):1343-1421. [2] 中华医学会内分泌学分会. 妊娠和产后甲状腺疾病诊治指南(第2版)[J]. 中华内分泌代谢杂志, 2019, 35(8):636-665. [3] 中华医学会内分泌学分会. 成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017, 33(02): 167-180. [4] Minasyan M, Dulęba A, Smalarz A, et al. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset[J]. Folia Med Cracov, 2020, 60(2):15-27. [5] Chiaki S , Kyoju A , Shin-Ichi T , et al. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels[J]. Journal of Clinical Endocrinology & Metabolism, 1987, 65(2):359-63. [6] Yoshimura Noh J, Momotani N, Fukada S, et al. Ratio of serum free triiodothyronine to free thyroxine in Graves’ hyperthyroidism and thyrotoxicosis caused by painless thyroiditis [J]. Endocrine J, 2005, 52(5):537-542. |